you are viewing a single comment's thread.
Trial enrollment is a an arduous process. Candidates must be screened and qualified and depending on how the treatment is manufactured requires time. Prerequisites must be met as well.I believe IMUC has over 21 sites enrolling for their phase 2 GBM trial and have been enrolling at a rapid pace. I like GERN I think its been way oversold.